Literature DB >> 9317001

Soluble antigens from group B streptococci induce cytokine production in human blood cultures.

C von Hunolstein1, A Totolian, G Alfarone, G Mancuso, V Cusumano, G Teti, G Orefici.   

Abstract

Group B streptococcal antigens stimulated tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1), and IL-6 production in human blood cultures in a concentration- and time-dependent fashion. The minimal concentrations of type-specific polysaccharides, lipoteichoic acid, and group-specific polysaccharide required to produce these effects were, respectively, 0.01, 1, and 10 microg/ml. Cell separation experiments indicated that monocytes were the cell type mainly responsible for cytokine production. Time course studies indicated that TNF-alpha was released before the other cytokines. TNF-alpha, however, did not appear to directly induce IL-1beta, as shown by blockade experiments with anti-TNF-alpha antibodies. IL-6 levels were moderately but significantly decreased by anti-TNF-alpha. These data indicate that several products from group B streptococci are able to directly stimulate human monocytes to release TNF-alpha, IL-1beta, and IL-6. These findings may be clinically relevant, since proinflammatory cytokines can mediate pathophysiologic changes during sepsis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317001      PMCID: PMC175577          DOI: 10.1128/iai.65.10.4017-4021.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Prospective diagnosis of early onset group B streptococcal infection by countercurrent immunoelectrophoresis.

Authors:  M S Edwards; C J Baker
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

2.  Correlation of plasma cytokine elevations with mortality rate in children with sepsis.

Authors:  J S Sullivan; L Kilpatrick; A T Costarino; S C Lee; M C Harris
Journal:  J Pediatr       Date:  1992-04       Impact factor: 4.406

3.  Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.

Authors:  L E DeForge; J S Kenney; M L Jones; J S Warren; D G Remick
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

4.  Stimulation of monokine production by lipoteichoic acids.

Authors:  S Bhakdi; T Klonisch; P Nuber; W Fischer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  Specificity and protective activity of murine monoclonal antibodies directed against the capsular polysaccharide of type III group B streptococci.

Authors:  G Teti; M Calapai; G Calogero; F Tomasello; G Mancuso; A Galli; G Riggio
Journal:  Hybridoma       Date:  1992-02

6.  Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

Authors:  C von Hunolstein; S D'Ascenzi; B Wagner; J Jelínková; G Alfarone; S Recchia; M Wagner; G Orefici
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis.

Authors:  E S de Bont; A Martens; J van Raan; G Samson; W P Fetter; A Okken; L H de Leij
Journal:  Pediatr Res       Date:  1993-04       Impact factor: 3.756

8.  Soluble group- and type-specific antigens from type III group B Streptococcus.

Authors:  R B Carey; T K Eisenstein; G D Shockman; T F Greber; R M Swenson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.

Authors:  G Teti; G Mancuso; F Tomasello
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Evaluation of a test system for measuring cytokine production in human whole blood cell cultures.

Authors:  U Elsässer-Beile; S von Kleist; H Gallati
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

View more
  20 in total

1.  Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  E A Albanyan; J G Vallejo; C W Smith; M S Edwards
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products.

Authors:  M Cuzzola; G Mancuso; C Beninati; C Biondo; C von Hunolstein; G Orefici; T Espevik; T H Flo; G Teti
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.

Authors:  Giuseppe Mancuso; Angelina Midiri; Carmelo Biondo; Concetta Beninati; Maria Gambuzza; Daniele Macrì; Antonella Bellantoni; Andrej Weintraub; Terje Espevik; Giuseppe Teti
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 4.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages.

Authors:  M Segura; J Stankova; M Gottschalk
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis.

Authors:  L Tissi; M Puliti; R Barluzzi; G Orefici; C von Hunolstein; F Bistoni
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Mitogenic effect contributes to increased virulence of Streptococcus suis sequence type 7 to cause streptococcal toxic shock-like syndrome.

Authors:  H Zheng; C Ye; M Segura; M Gottschalk; J Xu
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

8.  Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Authors:  Chee K Tan; Alison J Carey; Xiangqin Cui; Richard I Webb; Deepak Ipe; Michael Crowley; Allan W Cripps; William H Benjamin; Kimberly B Ulett; Mark A Schembri; Glen C Ulett
Journal:  Infect Immun       Date:  2012-06-25       Impact factor: 3.441

9.  Interleukin-1 inhibits gamma interferon-induced bacteriostasis in human uroepithelial cells.

Authors:  W Däubener; C Hucke; K Seidel; U Hadding; C R MacKenzie
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

10.  Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci.

Authors:  Hiroshige Mikamo; Atul K Johri; Lawrence C Paoletti; Lawrence C Madoff; Andrew B Onderdonk
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.